Bystander Selection for Antimicrobial Resistance: Implications for Patient Health

Valerie J. Morley, Robert J. Woods, Andrew F. Read

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Antimicrobial therapy promotes resistance emergence in target infections and in off-target microbiota. Off-target resistance emergence threatens patient health when off-target populations are a source of future infections, as they are for many important drug-resistant pathogens. However, the health risks of antimicrobial exposure in off-target populations remain largely unquantified, making rational antibiotic stewardship challenging. Here, we discuss the contribution of bystander antimicrobial exposure to the resistance crisis, the implications for antimicrobial stewardship, and some novel opportunities to limit resistance evolution while treating target pathogens.

Original languageEnglish (US)
Pages (from-to)864-877
Number of pages14
JournalTrends in Microbiology
Volume27
Issue number10
DOIs
StatePublished - Oct 2019

Fingerprint

Health Services Needs and Demand
Microbiota
Health
Infection
Anti-Bacterial Agents
Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Microbiology (medical)
  • Infectious Diseases
  • Virology

Cite this

Morley, Valerie J. ; Woods, Robert J. ; Read, Andrew F. / Bystander Selection for Antimicrobial Resistance : Implications for Patient Health. In: Trends in Microbiology. 2019 ; Vol. 27, No. 10. pp. 864-877.
@article{d8b340a8c0394474abc829dba9c93cda,
title = "Bystander Selection for Antimicrobial Resistance: Implications for Patient Health",
abstract = "Antimicrobial therapy promotes resistance emergence in target infections and in off-target microbiota. Off-target resistance emergence threatens patient health when off-target populations are a source of future infections, as they are for many important drug-resistant pathogens. However, the health risks of antimicrobial exposure in off-target populations remain largely unquantified, making rational antibiotic stewardship challenging. Here, we discuss the contribution of bystander antimicrobial exposure to the resistance crisis, the implications for antimicrobial stewardship, and some novel opportunities to limit resistance evolution while treating target pathogens.",
author = "Morley, {Valerie J.} and Woods, {Robert J.} and Read, {Andrew F.}",
year = "2019",
month = "10",
doi = "10.1016/j.tim.2019.06.004",
language = "English (US)",
volume = "27",
pages = "864--877",
journal = "Trends in Microbiology",
issn = "0966-842X",
publisher = "Elsevier Limited",
number = "10",

}

Bystander Selection for Antimicrobial Resistance : Implications for Patient Health. / Morley, Valerie J.; Woods, Robert J.; Read, Andrew F.

In: Trends in Microbiology, Vol. 27, No. 10, 10.2019, p. 864-877.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Bystander Selection for Antimicrobial Resistance

T2 - Implications for Patient Health

AU - Morley, Valerie J.

AU - Woods, Robert J.

AU - Read, Andrew F.

PY - 2019/10

Y1 - 2019/10

N2 - Antimicrobial therapy promotes resistance emergence in target infections and in off-target microbiota. Off-target resistance emergence threatens patient health when off-target populations are a source of future infections, as they are for many important drug-resistant pathogens. However, the health risks of antimicrobial exposure in off-target populations remain largely unquantified, making rational antibiotic stewardship challenging. Here, we discuss the contribution of bystander antimicrobial exposure to the resistance crisis, the implications for antimicrobial stewardship, and some novel opportunities to limit resistance evolution while treating target pathogens.

AB - Antimicrobial therapy promotes resistance emergence in target infections and in off-target microbiota. Off-target resistance emergence threatens patient health when off-target populations are a source of future infections, as they are for many important drug-resistant pathogens. However, the health risks of antimicrobial exposure in off-target populations remain largely unquantified, making rational antibiotic stewardship challenging. Here, we discuss the contribution of bystander antimicrobial exposure to the resistance crisis, the implications for antimicrobial stewardship, and some novel opportunities to limit resistance evolution while treating target pathogens.

UR - http://www.scopus.com/inward/record.url?scp=85068442497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068442497&partnerID=8YFLogxK

U2 - 10.1016/j.tim.2019.06.004

DO - 10.1016/j.tim.2019.06.004

M3 - Review article

C2 - 31288975

AN - SCOPUS:85068442497

VL - 27

SP - 864

EP - 877

JO - Trends in Microbiology

JF - Trends in Microbiology

SN - 0966-842X

IS - 10

ER -